Beijing Continent Pharmaceuticals Co., Ltd received approval from the China Securities Regulatory Commission for the business combination with Catalyst Biosciences, Inc. and other entities, with the completion anticipated by the Outside Date.
AI Assistant
GYRE THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.